Table 4.
Primary and secondary outcomes of AR-Centre and AR-Home participants after 20 training sessions (PP analysis)
| Outcome | AR-Centre (n = 23) | AR-Home (n = 16) | Mean | Group | ||||
|---|---|---|---|---|---|---|---|---|
| Pre | Post | Difference (p Value) | Pre | Post | Difference (p Value) | Difference (95% CI) | Difference p Value | |
| FMA-UE† | 40.09±19.69 | 43.65±19.41 | 3.57±4.93 | 37.06±20.91 | 40.81±20.01 | 3.75±4.46 | − 1.563 (− 3.318 | 0.906 |
| (Max. 66) | (0.0022**) | (0.0043**) | to 2.948) | |||||
| FMA-LE† | 19.48±8.18 | 24.00±6.43 | 4.52±5.48 | 17.44±8.50 | 20.50±9.21 | 3.06±3.75 | 2.000 (− 1.741 | 0.361 |
| (Max. 34) | (0.0007**) | (0.0052**) | to 4.659) | |||||
| BBS† | 41.35±13.05 | 43.22±12.59 | 1.87±5.42 | 40.25±10.32 | 43.00±6.02 | 2.75±6.21 | − 1.3125 (− 4.677 | 0.641 |
| (Max. 56) | (0.0438*) | (0.097) | to 2.916) | |||||
| FAC† | 4.65±1.19 | 4.78±1.17 | 0.13±0.87 | 4.38±1.15 | 4.72±1.32 | 0.34±1.01 | − 0.281 (− 0.826 | 0.485 |
| (Max. 6) | (0.480) | (0.194) | to 0.400) | |||||
| BI† | N/A | N/A | N/A | 16.31±2.73 | 17.56±2.53 | 1.25±1.18 | N/A | N/A |
| (Max. 20) | (0.0007**) | |||||||
| SF-12v2 PCS† | 32.75±14.09 | 37.58±10.37 | 4.83±9.79 | 31.61±9.39 | 36.42±9.99 | 4.81±8.35 | 0.888 (− 6.078 | 0.996 |
| (Max. 100) | (0.027*) | (0.036*) | to 6.105) | |||||
| SF-12v2 MCS† | 37.07±19.29 | 45.07±13.16 | 8.01± 14.87 | 45.68±12.68 | 46.21±9.18 | 0.53±8.47 | 8.878 (− 0.877 | 0.078 |
| (Max. 100) | (0.017*) | (0.807) | to 15.837) | |||||
FMA Fugl-Meyer Assessment, FMA-UE FMA for Upper-Extremity, FMA-LE FMA for Lower-Extremity, BBS Berg Balance Scale, FAC Functional Ambulation Category, BI Barthel Index of Activities of Daily Living, SF-12v2 The 12-Item Short Form Health Survey (PCS = Physical Component Summary and MCS = Mental Component Summary)
†Date are presented as mean ± SD
*p < 0.05; **p < 0.01